Related by context. Frequent words. (Click for all words.) 83 pivotal Phase III 82 randomized Phase 78 Phase III clinical 76 Phase 2b clinical 74 Phase 2a clinical 73 Phase 2b 73 Phase III 73 Phase IIb 72 Phase 2a 72 Phase 2b study 72 Phase IIb clinical 72 Phase 1b 71 Phase Ib 69 Phase 69 Phase IIa clinical 68 Phase III clinical trials 68 Phase IIa 67 Phase IIb trial 65 Phase II 65 Phase III trials 65 initiate Phase 65 dose escalation study 64 dose escalation 63 clinical trial 63 randomized placebo controlled 63 randomized double 63 placebo controlled 62 Special Protocol Assessment 62 randomized controlled 62 double blind placebo 61 PRX # 61 blind randomized placebo 60 hormone refractory prostate cancer 59 investigational compound 59 RDEA# 59 FOLOTYN 59 blind placebo controlled 58 investigational drug 58 multicenter 58 pharmacokinetic 58 prospective randomized 57 IMGN# 57 perifosine 57 blind randomized 57 RG# [001] 57 tolerability 57 T DM1 57 clinical trials 56 monotherapy 56 New Drug Application 56 picoplatin 56 satraplatin 56 Ceplene 56 mipomersen 56 carfilzomib 56 pharmacodynamics 56 oral formulation 56 preclinical 55 NDA submission 55 myelofibrosis 55 relapsing remitting multiple sclerosis 55 XL# [003] 55 tivozanib 55 INCB# [002] 55 randomized clinical 55 safety tolerability 55 evaluable patients 55 metastatic colorectal cancer 55 investigational 54 Genasense 54 VELCADE 54 ERBITUX 54 Clolar 54 nimotuzumab 54 CYT# 54 dosing regimens 54 NSCLC 54 APF# 54 naproxcinod 53 oral mucositis 53 DSMB 53 IDX# 53 pharmacokinetics 53 ZEVALIN 53 randomized 53 MDV# 53 Zenvia 52 pixantrone 52 sNDA 52 tolerability profile 52 LibiGel 52 Feraheme 52 Dacogen 52 pharmacodynamic 52 ADX# 52 primary endpoint 52 preclinical studies 52 New Drug IND 52 humanized monoclonal antibody 52 hematologic malignancies 52 efficacy